Cetraxate HCl

CAS No. 27724-96-5

Cetraxate HCl( DV 1006 | DV-1006 | DV1006 | Cetraxate hydrochloride )

Catalog No. M24187 CAS No. 27724-96-5

Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 88 In Stock
25MG 178 In Stock
50MG 335 In Stock
100MG 537 In Stock
500MG 1134 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cetraxate HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
  • Description
    Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DV 1006 | DV-1006 | DV1006 | Cetraxate hydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    27724-96-5
  • Formula Weight
    341.83
  • Molecular Formula
    C17H24ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oka M, Ichinose M, Fujishiro M, Omata M. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. Nihon Rinsho. 2005 Nov;63 Suppl 11:461-4. Japanese. PubMed PMID: 16363579.
molnova catalog
related products
  • Methysticin b

    Methysticin, a major kavalactone extracted from kava, can induce CYP1A1.

  • Fasoracetam

    Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.

  • BRD7389

    BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.